![MyNeuroNews](https://s3.amazonaws.com/weyland.altmetric.com/news_sources/logos/000/003/144/normal/Screenshot_2019-07-30_at_09.20.34.png?1564474985)
Erenumab in Chronic Migraine Patients Who Previously Failed Five First-Line Oral Prophylactics and OnabotulinumtoxinA: A Dual-Center Retrospective Observational Study
MyNeuroNews,
Background: German authorities reimburse migraine prevention with erenumab only in patients who previously did not have…